CTRB2

Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved in · Q6GPI1 · CTRB2 on Sugi Atlas →

3,725 patent compounds predicted against CTRB2, 3,340 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL13401721 SCHEMBL13401721 0.49 2/20
SCHEMBL13401747 SCHEMBL13401747 0.44 2/20
SCHEMBL13401736 SCHEMBL13401736 0.44 2/20
SCHEMBL15456413 SCHEMBL15456413 1.00 1/20
SCHEMBL15456517 SCHEMBL15456517 1.00 1/20
SCHEMBL15597198 SCHEMBL15597198 1.00 1/20
SCHEMBL15597251 SCHEMBL15597251 1.00 1/20
SCHEMBL16782297 SCHEMBL16782297 1.00 1/20
Milvexian Milvexian (SCHEMBL16971760) 0.91 1/20
Milvexian Milvexian (SCHEMBL16972161) 0.91 1/20
SCHEMBL15594051 SCHEMBL15594051 0.90 1/20
SCHEMBL15594137 SCHEMBL15594137 0.89 1/20
SCHEMBL16910511 SCHEMBL16910511 0.89 1/20
SCHEMBL15456817 SCHEMBL15456817 0.88 1/20
SCHEMBL15594071 SCHEMBL15594071 0.88 1/20
SCHEMBL15594200 SCHEMBL15594200 0.88 1/20
SCHEMBL15594046 SCHEMBL15594046 0.87 1/20
SCHEMBL15594274 SCHEMBL15594274 0.87 1/20
SCHEMBL15594140 SCHEMBL15594140 0.86 1/20
SCHEMBL15594199 SCHEMBL15594199 0.86 1/20

Clinical trials — most relevant to CTRB2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography PHASE4UNKNOWN
Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus PHASE4COMPLETED
A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema PHASE3COMPLETED
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock PHASE2/PHASE3COMPLETED
Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis PHASE1/PHASE2COMPLETED
Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study) PHASE2NOT_YET_RECRUITING
Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis nanCOMPLETED
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
Markers in Acute Pancreatitis-1 nanCOMPLETED
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) nanRECRUITING
Presepsin as a Predictor for Postoperative Complications Following Pancreatic Resection nanCOMPLETED
Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients nanCOMPLETED
Post Acute Pancreatitis Pancreatic Exocrine Insufficiency nanCOMPLETED
Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes nanCOMPLETED
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Epidemiology of APO- and Lipoproteins in Elderly Women nanCOMPLETED
Biomarker for Hereditary AngioEdema Disease nanCOMPLETED
Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome nanCOMPLETED
Belgian Antithrombin Deficiency Registry nanNOT_YET_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Effects of Vitamin D on Health Promotion During Pregnancy and Its Impact on Prematurity-Related Outcome nanUNKNOWN
Response Options to Blood Volume Monitoring in Fluid Overloaded Hemodialysis Patients nanCOMPLETED
Exocrine Pancreatic Function Testing in Cystic Fibrosis nanUNKNOWN
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3 nanCOMPLETED
Evaluation of Plasma Renin Concentrations in Cardiac Surgery nanRECRUITING
Genetic Modifiers of Cystic Fibrosis: Sibling Study nanCOMPLETED
Counter-Regulatory Hormonal and Stress Systems in Patients With COVID-19 nanCOMPLETED
Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures nanUNKNOWN
The North American Pancreatitis Study nanCOMPLETED
CTRP3 and Progranulin in Patients With Coronary Artery Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CTRB2 binder may also engage these)

ProteinNameSimilarity
CTRB1 Chymotrypsinogen B 1.000 landscape →
P04813 1.000 P04813 →
P00767 0.996 P00767 →
P07338 0.995 P07338 →
Q9CR35 0.995 Q9CR35 →
P80646 0.992 P80646 →
P00766 0.987 P00766 →
P47796 0.984 P47796 →
P15949 0.983 P15949 →
P00756 0.982 P00756 →
P00755 0.981 P00755 →
P80009 0.980 P80009 →
P29787 0.979 P29787 →
P00759 0.979 P00759 →
Q9JM71 0.979 Q9JM71 →
P04071 0.978 P04071 →
P07647 0.978 P07647 →
Q91508 0.978 Q91508 →
P15947 0.977 P15947 →
P80010 0.977 P80010 →
Q072L7 0.976 Q072L7 →
Q924N9 0.976 Q924N9 →
P15945 0.976 P15945 →
CTRL Chymotrypsin-like protease CTRL-1 0.976 landscape →
P81286 0.976 P81286 →
Q61754 0.975 Q61754 →
P36368 0.975 P36368 →
P51588 0.974 P51588 →
P36369 0.974 P36369 →
Q91507 0.974 Q91507 →